The Flu Vaccine in the COVID-19 Era: Reductions in ICU Admissions, Sepsis, and Strokes
Largest study of its kind suggests that the flu vaccine reduces ICU admissions, sepsis, and strokes, highlighting the potential benefits of influenza vaccination in reducing the burden on healthcare systems and improving patient outcomes during the COVID-19 pandemic.
Februery 2022
Effectiveness of Pfizer-BioNTech and Oxford/AstraZeneca Vaccines: Insights from Real-World Data
Large observational study from the United Kingdom demonstrates >60% protection against symptomatic COVID-19 with Pfizer-BioNTech and Oxford/AstraZeneca vaccines 28 days after one dose, supporting the effectiveness of COVID-19 vaccination in reducing disease transmission and severity.
Februery 2022
Post-Pfizer Vaccination Myocarditis in Adolescents: Case Series and Clinical Implications
Seven cases of symptomatic acute myocarditis are reported in adolescents following Pfizer-BioNTech COVID-19 vaccination, raising awareness about potential vaccine-related adverse events and informing ongoing surveillance and monitoring efforts.
January 2022
COVID-19 Vaccination in Breastfeeding Women: Insights from Antibody Secretion in Breast Milk
Breast milk from vaccinated mothers shows strong secretion of SARS-CoV-2-specific IgA and IgG antibodies for up to 6 weeks post-vaccination, supporting the safety and efficacy of COVID-19 vaccination in breastfeeding women and passive immunity transfer to infants.
December 2021
FDA and CDC Pause Use of Johnson & Johnson Vaccine: Safety Concerns
Following reports of rare blood clotting events, the FDA and CDC recommend a pause in the use of the Johnson & Johnson vaccine, highlighting the importance of post-authorization safety monitoring and rapid response to vaccine-related adverse events.
December 2021
Thrombosis Risk in COVID-19 and Vaccination: Comparative Assessment
Comparative analysis reveals a higher risk of thrombosis associated with COVID-19 infection than with COVID-19 vaccines, highlighting the importance of vaccination in mitigating the risk of severe thrombotic events and preventing COVID-19-related complications.
December 2021
